After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ARWR belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc is $2.49B. A total of 1.45 million shares were traded on the day, compared to an average of 1.98M shares.
In the most recent transaction, OLUKOTUN ADEOYE Y sold 959 shares of ARWR for 21.00 per share on Jan 23 ’25. After the transaction, the Director now owns 35,781 company shares. In a previous transaction on Jan 23 ’25, OLUKOTUN ADEOYE Y bought 959 shares at 20.97 per share.
Among the insiders who sold shares, Hamilton James C disposed of 32,729 shares on Jan 06 ’25 at a per-share price of $19.82. This resulted in the Chief Discovery/Trans Medicine holding 272,122 shares of ARWR after the transaction. In another insider transaction, O’Brien Patrick sold 29,184 shares at $19.82 per share on Jan 06 ’25. Company shares held by the COO and General Counsel now total 535,201.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARWR has a high of $36.72 and a low of $17.05.
As of this writing, ARWR has an earnings estimate of -$0.72 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $2.91 per share and a lower estimate of -$1.43.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $1.49, while its Total Shareholder’s Equity was $408.82M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.
